Our mission is to provide orthopaedic health care professionals with diagnostic tools to make better decisions and to deliver the best patient care.
We offer an easy, fast and quantitative Point of Care test (POCT) for Calprotectin in Synovial Fluid. The POCT is designed to give results within 15 minutes, and will aid in identifying the risk of prosthetic joint infection.
For more information contact email@example.com
Lyfstone® Calprotectin for Synovial Fluid has been developed in close collaboration with Calpro AS, a Norwegian company with more than 20 years of experience in providing high quality products and solutions for Calprotectin analysis in faeces, plasma/serum samples, enabling a variety of important diagnostic insights, including the assessment of IBD and rheumatic diseases and distinguishing bacterial from viral infections.
Calpro AS is the legal manufacturer of Lyfstone® Calprotectin for Synovial Fluid.
Finn Olav R. Elde
Chairman of the Board
Strategy, Legal, M&A
Management, IP, financing, commercialization, sales and marketing
Finance, accounting, compliance
Sales, industry relations, strategy and business development
Science and technology, product formulation, regulatory compliance
Diagnostic and clinical development, commercialization and exits
Finance and compliance
Anders Einung Hansen
Quality assurance, system and product development
Dirk van Hoegaerden
Sales, Europe and RoW, distributor management
Product development and documentation, Production management